I liked the price action here:
1) Increasingly large breakouts with pullbacks to prior level
2) Bullish megaphone pattern
3) Recent bullish wedge consolidation near resistance line
4) July '19 pullback consolidates atop July '17 top
BDSI sells buprenorphine formulations for pain management and opioid dependence management. Most recent quarter was a huge revenue beat and guidance raise.
1) Increasingly large breakouts with pullbacks to prior level
2) Bullish megaphone pattern
3) Recent bullish wedge consolidation near resistance line
4) July '19 pullback consolidates atop July '17 top
BDSI sells buprenorphine formulations for pain management and opioid dependence management. Most recent quarter was a huge revenue beat and guidance raise.
Komen:
Funny thing here is I was experimenting with stops, got stopped out on the pullback to $4.15, and I didn't make a single penny on this one
Komen:
Obviously it proceeded to run up +50% from that level